Latest Articles

Discover how a novel fluorescent probe, capable of probing early oligomeric pathology in neurodegenerative disease, could aid in the diagnosis of Alzheimer’s disease.

Trinity College Dublin’s Dr. Kevin Mitchell reviews the evidence behind claims that gut microbes cause autism. He argues that most microbiome studies are too small, inconsistent and confounded by diet and behavior.

At HUPO 2025, ETH Zurich’s Prof. Paola Picotti discussed how limited proteolysis mass spectrometry tracks protein shape changes rather than abundance alone. She highlighted how metabolite–protein interaction mapping can reveal functional shifts.

Technology Networks spoke with Dr. Samantha Pearman-Kanza to learn more about the benefits (and potential pitfalls) of going paperless in the lab and some of the research advancing digital technologies.

Dr. Tyler Brown discusses his experiences of working in STEMM and highlights how the industry can foster a more inclusive workplace culture.

From decoding the diversity of brain cells to probing pollinators, Prof. Leonard Foster explores how proteomics can help reveal connections between human health, the environment and the wider world.

This article explores how understanding the brain–immune ecosystem brings insights to the molecular mechanisms behind brain aging, facilitating research into immunotherapies for neurodegenerative diseases.

How can research labs reduce their environmental impact? Technology Networks asked two sustainability experts to find out.

The rise of digital science is reshaping lab sustainability. In this article, experts highlight the need for new standards to account for computing’s growing environmental impact.

Once dismissed as a party drug, MDMA is reemerging as a therapeutic option for treatment-resistant PTSD. Dr. Kenji Hashimoto explores MDMA’s neurobiological, gut–brain and vagus nerve effects while outlining safety, regulatory and clinical questions.